FDA.reportPublic FDA data

empagliflozin 12.5 MG / linagliptin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet

RxCUI
2359288
RxNorm name
empagliflozin 12.5 MG / linagliptin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet
Display name
empagliflozin 12.5 MG / linagliptin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet
Full name
empagliflozin 12.5 MG / linagliptin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Trijardy XREMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDEBoehringer Ingelheim Pharmaceuticals, Inc.71873567-9594-452a-bb92-34a129adecac2026-08-24Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2359288

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
71873567-9594-452a-bb92-34a129adecacempagliflozin 12.5 MG / linagliptin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR empagliflozin 12.5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [SCD] · empagliflozin 12.5 MG / linagliptin 2.5 MG / metformin HCl 1000 MG 24HR Extended Release Oral Tablet [SY]310These highlights do not include all the information needed to use TRIJARDY XR safely and effectively. See full prescribing information for TRIJARDY XR. TRIJARDY ® XR (empagliflozin, linagliptin, and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 202020260130